Approximately 11,832 bottles of Lisinopril and Hydrochlorothiazide Tablets USP (20 mg/12.5 mg) are being recalled after a report that a bottle contained a single foreign tablet of Fenofibrate (145 mg). Taking an incorrect medication like Fenofibrate when you intend to take blood pressure medication can lead to dangerous health complications or inadequate treatment of your condition. These prescription tablets were manufactured by Lupin Pharmaceuticals and distributed in 500-count bottles nationwide. Consumers who have this medication should check their bottles immediately and consult with their healthcare provider.
A foreign tablet (Fenofibrate) was found inside a bottle of Lisinopril and Hydrochlorothiazide, meaning patients could accidentally ingest the wrong medication. This poses a risk of unintended side effects from Fenofibrate or a lack of necessary blood pressure control from the missing Lisinopril dose.
Healthcare consultation and pharmacy return
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.